New meningitis vaccine could halt epidemics
A cheap new meningitis vaccine designed to treat a type of the disease common in Africa could significantly reduce or even halt future epidemics in Africa's so-called ``meningitis belt,'' scientists said on Wednesday.
A meningitis B vaccine to prevent the most common and dangerous strand of the disease has been approved for use in Europe.